528 related articles for article (PubMed ID: 24014289)
1. Alteration of the microRNA network during the progression of Alzheimer's disease.
Lau P; Bossers K; Janky R; Salta E; Frigerio CS; Barbash S; Rothman R; Sierksma AS; Thathiah A; Greenberg D; Papadopoulou AS; Achsel T; Ayoubi T; Soreq H; Verhaagen J; Swaab DF; Aerts S; De Strooper B
EMBO Mol Med; 2013 Oct; 5(10):1613-34. PubMed ID: 24014289
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation.
Lv Z; Hu L; Yang Y; Zhang K; Sun Z; Zhang J; Zhang L; Hao Y
Metab Brain Dis; 2018 Oct; 33(5):1711-1720. PubMed ID: 29961914
[TBL] [Abstract][Full Text] [Related]
4. Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer's Disease.
Wu Y; Xu J; Xu J; Cheng J; Jiao D; Zhou C; Dai Y; Chen Q
Tohoku J Exp Med; 2017 Jun; 242(2):129-136. PubMed ID: 28626163
[TBL] [Abstract][Full Text] [Related]
5. MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.
Absalon S; Kochanek DM; Raghavan V; Krichevsky AM
J Neurosci; 2013 Sep; 33(37):14645-59. PubMed ID: 24027266
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology.
Llorens F; Thüne K; Andrés-Benito P; Tahir W; Ansoleaga B; Hernández-Ortega K; Martí E; Zerr I; Ferrer I
J Mol Neurosci; 2017 Oct; 63(2):206-215. PubMed ID: 28871468
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
[TBL] [Abstract][Full Text] [Related]
8. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-322 Cluster Promotes Tau Phosphorylation via Targeting Brain-Derived Neurotrophic Factor.
Zhang J; Liu Z; Pei Y; Yang W; Xie C; Long S
Neurochem Res; 2018 Mar; 43(3):736-744. PubMed ID: 29464486
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
[TBL] [Abstract][Full Text] [Related]
12. The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster.
Pichler S; Gu W; Hartl D; Gasparoni G; Leidinger P; Keller A; Meese E; Mayhaus M; Hampel H; Riemenschneider M
Neurobiol Aging; 2017 Feb; 50():167.e1-167.e10. PubMed ID: 27816213
[TBL] [Abstract][Full Text] [Related]
13. Screening of microRNAs associated with Alzheimer's disease using oxidative stress cell model and different strains of senescence accelerated mice.
Zhang R; Zhang Q; Niu J; Lu K; Xie B; Cui D; Xu S
J Neurol Sci; 2014 Mar; 338(1-2):57-64. PubMed ID: 24423585
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-326 decreases tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in Alzheimer's disease.
He B; Chen W; Zeng J; Tong W; Zheng P
J Cell Physiol; 2020 Jan; 235(1):480-493. PubMed ID: 31385301
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
[TBL] [Abstract][Full Text] [Related]
16. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
Lugli G; Cohen AM; Bennett DA; Shah RC; Fields CJ; Hernandez AG; Smalheiser NR
PLoS One; 2015; 10(10):e0139233. PubMed ID: 26426747
[TBL] [Abstract][Full Text] [Related]
17. miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease.
Zhang QS; Liu W; Lu GX
J Biosci; 2017 Sep; 42(3):397-404. PubMed ID: 29358553
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-132/212 impairs S-nitrosylation balance and induces tau phosphorylation in Alzheimer's disease.
Wang Y; Veremeyko T; Wong AH; El Fatimy R; Wei Z; Cai W; Krichevsky AM
Neurobiol Aging; 2017 Mar; 51():156-166. PubMed ID: 28089352
[TBL] [Abstract][Full Text] [Related]
19. A New Discovery of MicroRNA-455-3p in Alzheimer's Disease.
Kumar S; Reddy PH
J Alzheimers Dis; 2019; 72(s1):S117-S130. PubMed ID: 31524168
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
Denk J; Boelmans K; Siegismund C; Lassner D; Arlt S; Jahn H
PLoS One; 2015; 10(5):e0126423. PubMed ID: 25992776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
